Toll like receptor (TLR)-induced differential expression of microRNAs (MiRs) promotes proper immune response against infections: A systematic review

Journal of Infection

Volumn 67, Issue 4, 2013, Pages 251-264

  Aalaei andabili, Seyed Hossein ^a   Rezaei, Nima ^a,b,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Infection; MicroRNAs; Toll like receptors

Indexed keywords

DECORIN; ENDOTOXIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 10; INTERLEUKIN 12P70; LIPOPOLYSACCHARIDE; LYMPHOCYTE ANTIGEN; MICRORNA; MICRORNA 101; MICRORNA 122; MICRORNA 146A; MICRORNA 147; MICRORNA 148; MICRORNA 155; MICRORNA 19; MICRORNA 200B; MICRORNA 200C; MICRORNA 21; MICRORNA 210; MICRORNA 466L; MICRORNA 511; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; MYELOID DIFFERENTIATION FACTOR 88; NOTCH1 RECEPTOR; PROGRAMMED DEATH 4 RECEPTOR; PROTEIN P105; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; CELL MATURATION; CROSS TOLERANCE; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; GRAFT REJECTION; HEPATITIS C; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INFECTION; INFLAMMATION; INFLAMMATORY DISEASE; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; REVIEW; SEPTIC SHOCK; SYSTEMATIC REVIEW; UPREGULATION;

EID: 84882911145     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.07.016     Document Type: Review

References (114)

1. Kawai T., Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009, 21(4):317-337. Epub 2009/02/28.
2. Kumar H., Kawai T., Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol 2011, 30(1):16-34. Epub 2011/01/18.
3. Medzhitov R., Janeway C.A. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997, 91(3):295-298. Epub 1997/11/18.
4. Hedayat M., Netea M.G., Rezaei N. Targeting of Toll-like receptors: a decade of progress in combating infectious diseases. Lancet Infect Dis 2011, 11(9):702-712.
5. Akira S., Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004, 4(7):499-511. Epub 2004/07/02.
6. Moghimpour Bijani F., Vallejo J.G., Rezaei N. Toll-like receptor signaling pathways in Cardiovascular diseases: challenges and opportunities. Int Rev Immunol 2012, 31(5):379-395.
7. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., et al. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 2004, 303(5663):1526-1529. Epub 2004/02/21.
8. Barton G.M., Medzhitov R. Toll-like receptor signaling pathways. Science 2003, 300(5625):1524-1525. Epub 2003/06/07.
9. Hedayat M., Takeda K., Rezaei N. Prophylactic and therapeutic implications of Toll-like receptor ligands. Med Res Rev 2012, 32(2):294-325.
10. Rezaei N. Therapeutic targeting of pattern-recognition receptors. Int Immunopharmacol 2006, 6(6):863-869.
11. Strober W. Epithelial cells pay a Toll for protection. Nat Med 2004, 10(9):898-900. Epub 2004/09/02.
12. O'Neill L.A., Sheedy F.J., McCoy C.E. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol 2011, 11(3):163-175. Epub 2011/02/19.
13. Karin M., Lawrence T., Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006, 124(4):823-835. Epub 2006/02/25.
14. Liu J. Control of protein synthesis and mRNA degradation by microRNAs. Curr Opin Cell Biol 2008, 20(2):214-221. Epub 2008/03/11.
15. Hatfield S.D., Shcherbata H.R., Fischer K.A., Nakahara K., Carthew R.W., Ruohola-Baker H. Stem cell division is regulated by the microRNA pathway. Nature 2005, 435(7044):974-978. Epub 2005/06/10.
16. Rodriguez A., Vigorito E., Clare S., Warren M.V., Couttet P., Soond D.R., et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007, 316(5824):608-611. Epub 2007/04/28.
17. Johnnidis J.B., Harris M.H., Wheeler R.T., Stehling-Sun S., Lam M.H., Kirak O., et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008, 451(7182):1125-1129. Epub 2008/02/19.
18. Tili E., Michaille J.J., Cimino A., Costinean S., Dumitru C.D., Adair B., et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. JImmunol 2007, 179(8):5082-5089. Epub 2007/10/04.
19. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297. Epub 2004/01/28.
20. Benakanakere M.R., Li Q., Eskan M.A., Singh A.V., Zhao J., Galicia J.C., et al. Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. J Biol Chem 2009, 284(34):23107-23115. Epub 2009/06/11.
21. Glynn L. Eblip critical appraisal checklist. Available from:. Visited at November 2012. http://wwwnihsie/pdf/EBL%2520Critical%2520Appraisal%2520Checklistpdf.
22. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006, 103(33):12481-12486. Epub 2006/08/04.
23. Ceppi M., Pereira P.M., Dunand-Sauthier I., Barras E., Reith W., Santos M.A., et al. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci U S A 2009, 106(8):2735-2740. Epub 2009/02/06.
24. Bai Y., Qian C., Qian L., Ma F., Hou J., Chen Y., et al. Integrin CD11b negatively regulates TLR9-triggered dendritic cell cross-priming by upregulating microRNA-146a. J Immunol 2012, 188(11):5293-5302. Epub 2012/05/04.
25. Tserel L., Runnel T., Kisand K., Pihlap M., Bakhoff L., Kolde R., et al. MicroRNA expression profiles of human blood monocyte-derived dendritic cells and macrophages reveal miR-511 as putative positive regulator of Toll-like receptor 4. J Biol Chem 2011, 286(30):26487-26495. Epub 2011/06/08.
26. Kerrigan A.M., Brown G.D. C-type lectins and phagocytosis. Immunobiology 2009, 214(7):562-575. Epub 2009/03/06.
27. Vasudevan S., Tong Y., Steitz J.A. Cell-cycle control of microRNA-mediated translation regulation. Cell Cycle 2008, 7(11):1545-1549. Epub 2008/05/13.
28. Schauvliege R., Janssens S., Beyaert R. Pellino proteins are more than scaffold proteins in TLR/IL-1R signalling: a role as novel RING E3-ubiquitin-ligases. FEBS Lett 2006, 580(19):4697-4702. Epub 2006/08/04.
29. Takaesu G., Kishida S., Hiyama A., Yamaguchi K., Shibuya H., Irie K., et al. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol Cell 2000, 5(4):649-658. Epub 2000/07/06.
30. McCoy C.E., Sheedy F.J., Qualls J.E., Doyle S.L., Quinn S.R., Murray P.J., et al. IL-10 inhibits miR-155 induction by Toll-like receptors. JBiol Chem 2010, 285(27):20492-20498. Epub 2010/05/04.
31. Liu X., Zhan Z., Xu L., Ma F., Li D., Guo Z., et al. MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIalpha. J Immunol 2010, 185(12):7244-7251. Epub 2010/11/12.
32. Herrmann T.L., Agrawal R.S., Connolly S.F., McCaffrey R.L., Schlomann J., Kusner D.J. MHC class II levels and intracellular localization in human dendritic cells are regulated by calmodulin kinase II. J Leukoc Biol 2007, 82(3):686-699. Epub 2007/06/26.
33. Nahid M.A., Satoh M., Chan E.K. MicroRNA in TLR signaling and endotoxin tolerance. Cell Mol Immunol 2011, 8(5):388-403. Epub 2011/08/09.
34. Nahid M.A., Satoh M., Chan E.K. Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J Immunol 2011, 186(3):1723-1734. Epub 2010/12/24.
35. Nahid M.A., Pauley K.M., Satoh M., Chan E.K. miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity. J Biol Chem 2009, 284(50):34590-34599. Epub 2009/10/21.
36. El Gazzar M., Yoza B.K., Hu J.Y., Cousart S.L., McCall C.E. Epigenetic silencing of tumor necrosis factor alpha during endotoxin tolerance. J Biol Chem 2007, 282(37):26857-26864. Epub 2007/07/25.
37. El Gazzar M., Church A., Liu T., McCall C.E. MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-alpha during TLR4-induced gene reprogramming. J Leukoc Biol 2011, 90(3):509-519. Epub 2011/05/13.
38. Lu L.F., Boldin M.P., Chaudhry A., Lin L.L., Taganov K.D., Hanada T., et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell. 2010, 142(6):914-929. Epub 2010/09/21.
39. Huang Y., Crawford M., Higuita-Castro N., Nana-Sinkam P., Ghadiali S.N. miR-146a regulates mechanotransduction and pressure-induced inflammation in small airway epithelium. Faseb J 2012, 26(8):3351-3364. Epub 2012/05/18.
40. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129(7):1401-1414. Epub 2007/07/03.
41. Liu G., Friggeri A., Yang Y., Park Y.J., Tsuruta Y., Abraham E. miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad Sci U S A 2009, 106(37):15819-15824. Epub 2009/09/02.
42. Eis P.S., Tam W., Sun L., Chadburn A., Li Z., Gomez M.F., et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 2005, 102(10):3627-3632. Epub 2005/03/02.
43. Tam W. Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA. Gene 2001, 274(1-2):157-167. Epub 2001/10/25.
44. Yin Q., Wang X., McBride J., Fewell C., Flemington E. B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element. J Biol Chem 2008, 283(5):2654-2662. Epub 2007/12/01.
45. Kanezaki R., Toki T., Yokoyama M., Yomogida K., Sugiyama K., Yamamoto M., et al. Transcription factor BACH1 is recruited to the nucleus by its novel alternative spliced isoform. J Biol Chem 2001, 276(10):7278-7284. Epub 2000/11/09.
46. Yin Q., McBride J., Fewell C., Lacey M., Wang X., Lin Z., et al. MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J Virol 2008, 82(11):5295-5306. Epub 2008/03/28.
47. O'Connell R.M., Taganov K.D., Boldin M.P., Cheng G., Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 2007, 104(5):1604-1609. Epub 2007/01/24.
48. Calder C.J., Nicholson L.B., Dick A.D. A selective role for the TNF p55 receptor in autocrine signaling following IFN-gamma stimulation in experimental autoimmune uveoretinitis. J Immunol 2005, 175(10):6286-6293. Epub 2005/11/08.
49. Lau N.C., Lim L.P., Weinstein E.G., Bartel D.P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001, 294(5543):858-862. Epub 2001/10/27.
50. * cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood 2010, 116(26):5885-5894. Epub 2010/09/21.
51. Kobayashi K., Hernandez L.D., Galan J.E., Janeway C.A., Medzhitov R., Flavell R.A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002, 110(2):191-202. Epub 2002/08/02.
52. O'Garra A., Barrat F.J., Castro A.G., Vicari A., Hawrylowicz C. Strategies for use of IL-10 or its antagonists in human disease. Immunol Rev 2008, 223:114-131. Epub 2008/07/11.
53. Parsa K.V., Ganesan L.P., Rajaram M.V., Gavrilin M.A., Balagopal A., Mohapatra N.P., et al. Macrophage pro-inflammatory response to Francisella novicida infection is regulated by SHIP. PLoS Pathog 2006, 2(7):e71. Epub 2006/07/20.
54. Sun Y., Cai J., Ma F., Lu P., Huang H., Zhou J. miR-155 mediates suppressive effect of progesterone on TLR3, TLR4-triggered immune response. Immunol Lett 2012, 146(1-2):25-30. Epub 2012/05/02.
55. Fu H., Song S., Liu F., Ni Z., Tang Y., Shen X., et al. Dendritic cells transduced with SOCS1 gene exhibit regulatory DC properties and prolong allograft survival. Cell Mol Immunol 2009, 6(2):87-95. Epub 2009/05/01.
56. Zhang M., Zhang Q., Liu F., Yin L., Yu B., Wu J. MicroRNA-155 may affect allograft survival by regulating the expression of suppressor of cytokine signaling 1. Med Hypotheses 2011, 77(4):682-684. Epub 2011/08/02.
57. Pasquinelli A.E., Reinhart B.J., Slack F., Martindale M.Q., Kuroda M.I., Maller B., et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000, 408(6808):86-89. Epub 2000/11/18.
58. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403(6772):901-906. Epub 2000/03/08.
59. Chen X.M., Splinter P.L., O'Hara S.P., LaRusso N.F. A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J Biol Chem 2007, 282(39):28929-28938. Epub 2007/07/31.
60. Hu G., Zhou R., Liu J., Gong A.Y., Eischeid A.N., Dittman J.W., et al. MicroRNA-98 and let-7 confer cholangiocyte expression of cytokine-inducible Src homology 2-containing protein in response to microbial challenge. J Immunol 2009, 183(3):1617-1624. Epub 2009/07/14.
61. Hu G., Zhou R., Liu J., Gong A.Y., Chen X.M. MicroRNA-98 and let-7 regulate expression of suppressor of cytokine signaling 4 in biliary epithelial cells in response to Cryptosporidium parvum infection. J Infect Dis 2010, 202(1):125-135. Epub 2010/05/22.
62. Burgess-Beusse B.L., Darlington G.J. C/EBPalpha is critical for the neonatal acute-phase response to inflammation. Mol Cell Biol 1998, 18(12):7269-7277. Epub 1998/11/20.
63. O'Hara S.P., Splinter P.L., Gajdos G.B., Trussoni C.E., Fernandez-Zapico M.E., Chen X.M., et al. NFkappaB p50-CCAAT/enhancer-binding protein beta (C/EBPbeta)-mediated transcriptional repression of microRNA let-7i following microbial infection. J Biol Chem 2010, 285(1):216-225. Epub 2009/11/12.
64. Schulte L.N., Eulalio A., Mollenkopf H.J., Reinhardt R., Vogel J. Analysis of the host microRNA response to Salmonella uncovers the control of major cytokines by the let-7 family. Embo J 2011, 30(10):1977-1989. Epub 2011/04/07.
65. He L., Thomson J.M., Hemann M.T., Hernando-Monge E., Mu D., Goodson S., et al. A microRNA polycistron as a potential human oncogene. Nature 2005, 435(7043):828-833. Epub 2005/06/10.
66. Gantier M.P., Stunden H.J., McCoy C.E., Behlke M.A., Wang D., Kaparakis-Liaskos M., et al. A miR-19 regulon that controls NF-kappaB signaling. Nucleic Acids Res 2012, 40(16):8048-8058. Epub 2012/06/12.
67. Pichiorri F., Suh S.S., Ladetto M., Kuehl M., Palumbo T., Drandi D., et al. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci U S A 2008, 105(35):12885-12890. Epub 2008/08/30.
68. Yu Z., Willmarth N.E., Zhou J., Katiyar S., Wang M., Liu Y., et al. microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci U S A 2010, 107(18):8231-8236. Epub 2010/04/22.
69. Sheedy F.J., Palsson-McDermott E., Hennessy E.J., Martin C., O'Leary J.J., Ruan Q., et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 2010, 11(2):141-147. Epub 2009/12/01.
70. Talotta F., Cimmino A., Matarazzo M.R., Casalino L., De Vita G., D'Esposito M., et al. An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene 2009, 28(1):73-84. Epub 2008/10/14.
71. Merline R., Moreth K., Beckmann J., Nastase M.V., Zeng-Brouwers J., Tralhao J.G., et al. Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21. Sci Signal 2011, 4(199). ra75. Epub 2011/11/17.
72. Stoecklin G., Tenenbaum S.A., Mayo T., Chittur S.V., George A.D., Baroni T.E., et al. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J Biol Chem 2008, 283(17):11689-11699. Epub 2008/02/08.
73. Tone M., Powell M.J., Tone Y., Thompson S.A., Waldmann H. IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3. J Immunol 2000, 165(1):286-291. Epub 2000/06/22.
74. Ma F., Liu X., Li D., Wang P., Li N., Lu L., et al. MicroRNA-466l upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolin-mediated IL-10 mRNA degradation. J Immunol 2010, 184(11):6053-6059. Epub 2010/04/23.
75. Jing Q., Huang S., Guth S., Zarubin T., Motoyama A., Chen J., et al. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 2005, 120(5):623-634. Epub 2005/03/16.
76. Qi J., Qiao Y., Wang P., Li S., Zhao W., Gao C. microRNA-210 negatively regulates LPS-induced production of proinflammatory cytokines by targeting NF-kappaB1 in murine macrophages. FEBS Lett 2012, 586(8):1201-1207. Epub 2012/05/12.
77. Wendlandt E.B., Graff J.W., Gioannini T.L., McCaffrey A.P., Wilson M.E. The role of MicroRNAs miR-200b and miR-200c in TLR4 signaling and NF-kappaB activation. Innate Immun 2012, Epub 2012/04/24.
78. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008, 10(5):593-601. Epub 2008/04/01.
79. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132(3):344-362. Epub 2008/02/13.
80. Ghisletti S., Huang W., Jepsen K., Benner C., Hardiman G., Rosenfeld M.G., et al. Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways. Genes Dev 2009, 23(6):681-693. Epub 2009/03/21.
81. Zhu Q.Y., Liu Q., Chen J.X., Lan K., Ge B.X. MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages. J Immunol 2010, 185(12):7435-7442. Epub 2010/11/12.
82. Liu Y., Shepherd E.G., Nelin L.D. MAPK phosphatases-regulating the immune response. Nat Rev Immunol 2007, 7(3):202-212. Epub 2007/02/24.
83. Boutros T., Nantel A., Emadali A., Tzimas G., Conzen S., Chevet E., et al. The MAP kinase phosphatase-1 MKP-1/DUSP1 is a regulator of human liver response to transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surgeons 2008, 8(12):2558-2568. Epub 2008/11/27.
84. Barnes P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008, 8(3):183-192. Epub 2008/02/16.
85. Ogawa R., Tanaka C., Sato M., Nagasaki H., Sugimura K., Okumura K., et al. Adipocyte-derived microvesicles contain RNA that is transported into macrophages and might be secreted into blood circulation. Biochem Biophys Res Commun 2010, 398(4):723-729. Epub 2010/07/14.
86. Yamakuchi M., Lotterman C.D., Bao C., Hruban R.H., Karim B., Mendell J.T., et al. P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci U S A 2010, 107(14):6334-6339. Epub 2010/03/24.
87. Varga T., Czimmerer Z., Nagy L. PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim Biophys Acta 2011, 1812(8):1007-1022. Epub 2011/03/09.
88. Hennessy E.J., Sheedy F.J., Santamaria D., Barbacid M., O'Neill L.A. Toll-like receptor-4 (TLR4) down-regulates microRNA-107, increasing macrophage adhesion via cyclin-dependent kinase 6. J Biol Chem 2011, 286(29):25531-25539. Epub 2011/06/02.
89. Chassin C., Kocur M., Pott J., Duerr C.U., Gutle D., Lotz M., et al. miR-146a mediates protective innate immune tolerance in the neonate intestine. Cell Host Microbe 2010, 8(4):358-368. Epub 2010/10/19.
90. Hou J., Wang P., Lin L., Liu X., Ma F., An H., et al. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 2009, 183(3):2150-2158. Epub 2009/07/15.
91. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004, 5(7):730-737. Epub 2004/06/23.
92. Cremer T.J., Ravneberg D.H., Clay C.D., Piper-Hunter M.G., Marsh C.B., Elton T.S., et al. MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response. PLoS One 2009, 4(12):e8508. Epub 2009/12/31.
93. Wang P., Hou J., Lin L., Wang C., Liu X., Li D., et al. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. JImmunol 2010, 185(10):6226-6233. Epub 2010/10/13.
94. Gatto G., Rossi A., Rossi D., Kroening S., Bonatti S., Mallardo M. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Nucleic Acids Res 2008, 36(20):6608-6619. Epub 2008/10/23.
95. Koch M., Mollenkopf H.J., Klemm U., Meyer T.F. Induction of microRNA-155 is TLR- and type IV secretion system-dependent in macrophages and inhibits DNA-damage induced apoptosis. Proc Natl Acad Sci U S A 2012, 109(19):E1153-E1162. Epub 2012/04/18.
96. Xiao B., Liu Z., Li B.S., Tang B., Li W., Guo G., et al. Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. JInfect Dis 2009, 200(6):916-925. Epub 2009/08/05.
97. Sheridan C., Brumatti G., Elgendy M., Brunet M., Martin S.J. An ERK-dependent pathway to Noxa expression regulates apoptosis by platinum-based chemotherapeutic drugs. Oncogene 2010, 29(49):6428-6441. Epub 2010/08/31.
98. Ghorpade D.S., Leyland R., Kurowska-Stolarska M., Patil S.A., Balaji K.N. MicroRNA-155 is required for Mycobacterium bovis BCG-mediated apoptosis of macrophages. Mol Cell Biol 2012, 32(12):2239-2253. Epub 2012/04/05.
99. Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 1997, 387(6636):924-929. Epub 1997/06/26.
100. Zitzmann K., Brand S., De Toni E.N., Baehs S., Goke B., Meinecke J., et al. SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells. Cancer Res 2007, 67(10):5025-5032. Epub 2007/05/19.
101. Lu F., Weidmer A., Liu C.G., Volinia S., Croce C.M., Lieberman P.M. Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J Virol 2008, 82(21):10436-10443. Epub 2008/08/30.
102. Swaminathan G, Rossi F, Sierra LJ, Gupta A, Navas-Martín S, Martín-Garcia J. A role for miR-155 modulation in the anti-HIV-1 effects of TLR3 stimulation in macrophages. Poster presentation in Drexel Molecular Medicine and Infectious Disease Institute. 2011.
103. Swaminathan G., Rossi F., Sierra L.J., Gupta A., Navas-Martin S., Martin-Garcia J. A role for microRNA-155 modulation in the anti-HIV-1 effects of Toll-like receptor 3 stimulation in macrophages. PLoS Pathog 2012, 8(9):e1002937. Epub 2012/10/03.
104. Beltan E., Horgen L., Rastogi N. Secretion of cytokines by human macrophages upon infection by pathogenic and non-pathogenic mycobacteria. Microb Pathogenesis 2000, 28(5):313-318. Epub 2000/05/09.
105. Rajaram M.V., Ni B., Morris J.D., Brooks M.N., Carlson T.K., Bakthavachalu B., et al. Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b. Proc Natl Acad Sci U S A 2011, 108(42):17408-17413. Epub 2011/10/05.
106. Quesniaux V.J., Nicolle D.M., Torres D., Kremer L., Guerardel Y., Nigou J., et al. Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J Immunol 2004, 172(7):4425-4434. Epub 2004/03/23.
107. Schorey J.S., Cooper A.M. Macrophage signalling upon mycobacterial infection: the MAP kinases lead the way. Cell Microbiol 2003, 5(3):133-142. Epub 2003/03/05.
108. Hitti E., Iakovleva T., Brook M., Deppenmeier S., Gruber A.D., Radzioch D., et al. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol 2006, 26(6):2399-2407. Epub 2006/03/02.
109. Bala S., Marcos M., Kodys K., Csak T., Catalano D., Mandrekar P., et al. Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease. J Biol Chem 2011, 286(2):1436-1444. Epub 2010/11/11.
110. O'Connell R.M., Chaudhuri A.A., Rao D.S., Baltimore D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci U S A 2009, 106(17):7113-7118. Epub 2009/04/11.
111. Cheng J.C., Yeh Y.J., Tseng C.P., Hsu S.D., Chang Y.L., Sakamoto N., et al. Let-7b is a novel regulator of hepatitis C virus replication. Cell Mol Life Sci CMLS 2012, 69(15):2621-2633. Epub 2012/03/07.
112. Li S., Xing X., Yang Q., Xu H., He J., Chen Z., et al. The effects of hepatitis C virus core protein on the expression of miR-122 invitro. Virol J 2013, 10:98. Epub 2013/03/30.
113. Su T.H., Liu C.H., Liu C.J., Chen C.L., Ting T.T., Tseng T.C., et al. Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C. Proc Natl Acad Sci U S A 2013, 110(19):7844-7849. Epub 2013/04/25.
114. Sendi H. Dual role of miR-122 in Molecular pathogenesis of viral hepatitis. Hepat Monthly 2012, 12(5):312-314. Epub 2012/07/12.